Supplier
Allina Health System
Allina Health System was paid $10.77M by Medicaid between Jan 2018 and Dec 2024, across 170 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 31% of everything it billed.
33Billing provider infoALLINA HEALTH SYSTEM
ST PAUL, MN 55108
ST PAUL, MN 55108
33aNPI1023314804assigned 01/27/2011
33bProvider typeDurable Medical Equipment & Medical Supplies
28Total paid$10.77M
24GClaims335,607
24DCodes billed170
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Durable Medical Equipment & Medical Supplies providers in Minnesota
Rank by total paid#17 of 319
Median peer was paid$23K
This provider vs. median465×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official TALLARICO, DOMINICA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 60,281 | $561K | |
| 2019 | 64,088 | $2.18M | |
| 2020 | 50,176 | $1.81M | |
| 2021 | 60,087 | $2.33M | |
| 2022 | 38,789 | $1.51M | |
| 2023 | 35,603 | $1.34M | |
| 2024incomplete | 26,583 | $1.05M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 31% | 50,034 | 44,497 | $3.39M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 17% | 38,162 | 34,885 | $1.83M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 3.7% | 6,375 | 6,116 | $403K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 3.1% | 10,227 | 10,030 | $329K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 2.6% | 3,743 | 3,658 | $280K |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 2.4% | 4,197 | 2,849 | $264K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.4% | 3,105 | 3,014 | $256K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 2.3% | 2,858 | 2,795 | $244K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.1% | 3,229 | 3,187 | $230K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 2.0% | 2,243 | 2,080 | $217K |
| X5622 | 2.0% | 4,338 | 4,183 | $213K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.6% | 2,385 | 2,361 | $173K |
158 more codes
| 99204 | Doctor's office visit, new patient (more involved) | 1.6% | 1,832 | $170K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.4% | 2,371 | $151K |
| 36415 | Collection of venous blood by venipuncture | 1.0% | 31,548 | $108K |
| E0601 | Continuous positive airway pressure (cpap) device | <1% | 2,679 | $103K |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | <1% | 13,526 | $92K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 1,106 | $92K |
| 92015 | Determination of refractive state | <1% | 7,910 | $90K |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | <1% | 3,710 | $86K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 1,054 | $81K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 2,254 | $77K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 2,243 | $76K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 5,345 | $75K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 2,191 | $66K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 7,732 | $66K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 923 | $63K |
| A4604 | Tubing with integrated heating element for use with positive airway pressure device | <1% | 1,391 | $59K |
| 80061 | Lipid panel | <1% | 4,641 | $58K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 2,430 | $57K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,344 | $51K |
| 92551 | <1% | 7,137 | $48K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,653 | $46K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 642 | $46K |
| A7034 | Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap | <1% | 692 | $45K |
| V2020 | Frames, purchases | <1% | 2,099 | $45K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 1,161 | $44K |
| 90686 | <1% | 7,376 | $44K | |
| 99188 | <1% | 4,026 | $44K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,620 | $41K |
| 99243 | <1% | 429 | $39K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 4,092 | $38K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,710 | $37K |
| V2103 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | <1% | 1,703 | $34K |
| 92567 | <1% | 3,049 | $29K | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 567 | $29K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 4,649 | $28K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 1,160 | $28K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,603 | $28K |
| A7032 | Cushion for use on nasal mask interface, replacement only, each | <1% | 908 | $27K |
| 91322 | <1% | 212 | $26K | |
| 80053 | Comprehensive metabolic panel | <1% | 2,434 | $25K |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 595 | $23K |
| A7038 | Filter, disposable, used with positive airway pressure device | <1% | 3,418 | $20K |
| 92557 | <1% | 812 | $20K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,259 | $19K |
| 86780 | <1% | 1,239 | $16K | |
| 90651 | <1% | 745 | $16K | |
| 73630 | <1% | 737 | $16K | |
| A7035 | Headgear used with positive airway pressure device | <1% | 676 | $14K |
| 0002A | <1% | 397 | $13K | |
| 97810 | <1% | 512 | $13K | |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | <1% | 465 | $13K |
| 85027 | <1% | 2,041 | $12K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,574 | $12K |
| 97811 | <1% | 513 | $12K | |
| 81514 | <1% | 41 | $11K | |
| 90480 | <1% | 477 | $11K | |
| A7031 | Face mask interface, replacement for full face mask, each | <1% | 218 | $10K |
| 81025 | <1% | 1,527 | $10K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 303 | $10K |
| 92341 | <1% | 315 | $10K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 27 | $10K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 143 | $9K |
| 90715 | <1% | 635 | $9K | |
| 81001 | <1% | 3,367 | $9K | |
| 99173 | <1% | 5,968 | $9K | |
| 86803 | <1% | 576 | $9K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,197 | $8K |
| V2784 | Lens, polycarbonate or equal, any index, per lens | <1% | 948 | $8K |
| 0001A | <1% | 320 | $8K | |
| 87210 | <1% | 1,821 | $8K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 111 | $8K |
| 99177 | <1% | 1,457 | $8K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 201 | $7K |
| 0054A | <1% | 169 | $7K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,081 | $7K |
| 0071A | <1% | 199 | $6K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 83 | $6K |
| 0072A | <1% | 157 | $6K | |
| 90670 | <1% | 1,760 | $6K | |
| 0124A | <1% | 180 | $6K | |
| A7030 | Full face mask used with positive airway pressure device, each | <1% | 59 | $6K |
| 80047 | <1% | 621 | $6K | |
| A7046 | Water chamber for humidifier, used with positive airway pressure device, replacement, each | <1% | 518 | $6K |
| 87081 | <1% | 1,871 | $6K | |
| 96127 | <1% | 1,425 | $5K | |
| 90691 | <1% | 42 | $5K | |
| A7033 | Pillow for use on nasal cannula type interface, replacement only, pair | <1% | 239 | $5K |
| 87481 | <1% | 122 | $4K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 114 | $4K |
| A7039 | Filter, non disposable, used with positive airway pressure device | <1% | 527 | $4K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 299 | $4K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 27 | $4K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 101 | $4K |
| 85018 | <1% | 1,471 | $3K | |
| 31575 | <1% | 30 | $3K | |
| 0004A | <1% | 85 | $3K | |
| 93000 | <1% | 314 | $2K | |
| 17110 | <1% | 44 | $2K | |
| 0012A | <1% | 83 | $2K | |
| 0011A | <1% | 88 | $2K | |
| 90656 | <1% | 208 | $2K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 186 | $2K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 35 | $2K |
| 80076 | <1% | 214 | $2K | |
| 0031A | <1% | 78 | $2K | |
| G0008 | Administration of influenza virus vaccine | <1% | 322 | $2K |
| 31231 | <1% | 12 | $1K | |
| 82728 | <1% | 101 | $1K | |
| 90694 | <1% | 31 | $1K | |
| 69210 | <1% | 44 | $1K | |
| 0051A | <1% | 33 | $1K | |
| 0052A | <1% | 31 | $1K | |
| 99000 | <1% | 362 | $1K | |
| 87340 | <1% | 120 | $1K | |
| 76830 | Ultrasound, transvaginal | <1% | 13 | $1K |
| 81003 | <1% | 771 | $1K | |
| 92587 | <1% | 80 | $1K | |
| 90653 | <1% | 12 | $1K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 69 | $998.21 |
| 90716 | <1% | 913 | $958.16 | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 12 | $952.08 |
| 90707 | <1% | 641 | $889.23 | |
| 82043 | <1% | 138 | $805.50 | |
| V2100 | Sphere, single vision, plano to plus or minus 4.00, per lens | <1% | 79 | $800.66 |
| 82248 | <1% | 161 | $707.10 | |
| V2104 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, 2.12 to 4.00d cylinder, per lens | <1% | 28 | $622.71 |
| 90677 | <1% | 191 | $571.36 | |
| 90734 | <1% | 370 | $552.17 | |
| 87186 | <1% | 55 | $516.89 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 53 | $463.95 |
| 87077 | <1% | 52 | $451.67 | |
| 90714 | <1% | 14 | $379.24 | |
| 92593 | <1% | 12 | $336.91 | |
| 36416 | <1% | 113 | $298.58 | |
| 83550 | <1% | 28 | $257.27 | |
| 83540 | <1% | 29 | $197.23 | |
| 82607 | <1% | 12 | $186.39 | |
| 87338 | <1% | 12 | $180.87 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 26 | $150.00 |
| 99401 | <1% | 13 | $135.90 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 25 | $113.68 |
| 82565 | <1% | 15 | $82.80 | |
| 85652 | <1% | 28 | $78.03 | |
| 86140 | <1% | 13 | $66.48 | |
| 85651 | <1% | 40 | $59.41 | |
| 90647 | <1% | 1,191 | $54.18 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 38 | $25.46 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 27 | $12.84 |
| 90633 | 0% | 860 | $0.00 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 526 | $0.00 |
| 91300 | 0% | 20 | $0.00 | |
| 91321 | 0% | 75 | $0.00 | |
| 90681 | 0% | 154 | $0.00 | |
| 90700 | 0% | 40 | $0.00 | |
| 82947 | 0% | 12 | $0.00 | |
| 90723 | 0% | 1,375 | $0.00 | |
| 90696 | 0% | 87 | $0.00 | |
| 90688 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTALLARICO, DOMINICA (COO)
| Provider | Location | Paid |
|---|---|---|
| Allina Health System | Saint Paul, MN | $118.02M |
| Allina Health System | Coon Rapids, MN | $22.13M |
| Allina Health System | Minneapolis, MN | $18.26M |
| Allina Health System | Cambridge, MN | $13.17M |
| Allina Health System | Faribault, MN | $7.56M |
| Allina Health System | New Ulm, MN | $7.47M |
| Allina Health System | Fridley, MN | $7.34M |
| Allina Health System | Woodbury, MN | $5.49M |
| Allina Health System | Minneapolis, MN | $5.35M |
| Allina Health System | Bloomington, MN | $4.38M |
| Allina Health System | Northfield, MN | $4.36M |
| Allina Health System | Hastings, MN | $4.22M |
| Allina Health System | Maplewood, MN | $4.15M |
| Allina Health System | West St Paul, MN | $3.64M |
| Allina Health System | Cottage Grove, MN | $3.63M |
| Allina Health System | Minneapolis, MN | $3.54M |
| Allina Health System | Eagan, MN | $3.39M |
| Allina Health System | St Paul, MN | $3.35M |
| Allina Health System | Shakopee, MN | $2.81M |
| Allina Health System | Eden Prairie, MN | $2.71M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.